Back

Genetically tailored therapy with flecainide for familial dilated cardiomyopathy

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Rare inherited cardiac conditions Clinical EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jose Antonio Fernandez Sanchez

Virgen de las Nieves University Hospital, Granada (Spain)

3 More presentations in this session

Presentation thumbnail
First documented clinical case of arrhythmogenic heterozygous TECRL variant
Doctor A. Porretta (Paris, FR)
Slides Video
Presentation thumbnail
A novel mutation in LIM domain-binding protein 3 (LDB3) responsible for cardiomyopathy in association with ventricular preexcitation and conduction abnormalities
Doctor D. Siddharthan (New Delhi, IN)
Slides Video
Presentation thumbnail
A rare case of Andersen-Tawil Syndrome Type-1 with concealed clinical features
Associate Professor B. Hunuk (Istanbul, TR)
Slides Video

Access the full session

Session thumbnail
Rare inherited cardiac conditions

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Clinical reclassification of a desmin variant associated with dilated cardiomyopathy
thumbnail
Congress Presentation
A new phenotypic presentation of the p.Gly1743Arg variant in SCN5A classically associated with Brugada syndrome.
thumbnail
Congress Presentation
Ablation of premature ventricular complex that triggers VF in a patient with Emery-Dreifuss cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources